The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
METGastric: A phase III study of onartuzumab plus mFOLFOX6 in patients with metastatic HER2-negative (HER2-) and MET-positive (MET+) adenocarcinoma of the stomach or gastroesophageal junction (GEC).
 
Manish A. Shah
Research Funding - Bayer/Onyx (Inst); Genentech (Inst); Sanofi (Inst)
 
Yung-Jue Bang
Honoraria - Genentech
Consulting or Advisory Role - Genentech
Research Funding - Genentech (Inst)
 
Florian Lordick
Research Funding - Fresenius Biotech (Inst); GlaxoSmithKline (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Lilly; Merck; Roche Pharma AG
 
Josep Tabernero
Consulting or Advisory Role - Amgen; Celgene; Chugai Pharma; ImClone Systems; Lilly; Merck KGaA; Millennium; Novartis; Roche/Genentech; Sanofi; Symphony Evolution; Taiho Pharmaceutical
 
Meng Chen
Employment - Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Stephen Paul Hack
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
See-Chun Phan
Employment - Genentech
Stock and Other Ownership Interests - Roche Pharma AG
Consulting or Advisory Role - Bayer
Patents, Royalties, Other Intellectual Property - Genentech
 
David S. Shames
Employment - Genentech
Stock and Other Ownership Interests - Roche Pharma AG
Research Funding - University of Texas Southwestern Medical Center - Simmons Cancer Center
 
David Cunningham
Research Funding - Amgen; AstraZeneca; Celgene; MedImmune; Merck Serono; Merrimack; Sanofi